The Mexican unit of Germany's Volkswagen AG said on Monday the automaker was ready to restart operations in the states of Puebla and Guanajuato on June 15 after activity was idled in late March due to the coronavirus pandemic.
Nestle said on Monday it would appeal a Dutch court's ruling that prohibits the Swiss food giant from selling its plant-based burgers in Europe under the "Incredible Burger" name after a challenge from U.S.-based Impossible Foods.
FORMER regional chief operating officer (COO) of Morgan Stanley Asia Private Wealth Management (PWM), Sim Hwee Hoon, has joined robo-adviser StashAway’s board of directors as an independent non-executive director.
A top Aston Martin shareholder cut its stake in the British carmaker by nearly 5per cent, a regulatory filing showed on Monday.
U.S. manufacturing activity eased off an 11-year low in May, the strongest sign yet that the worst of the economic downturn was behind as businesses reopen, though the recovery from the COVID-19 crisis could take years because of high unemployment.
FRANKFURT: Lufthansa's supervisory board has approved a 9 billion euro (US$10 billion) government bailout that will force the German airline to give some of its prized landing slots to rivals. The approval marks the latest step in the complex state rescue of Lufthansa, which has been badly hit by...
REUTERS: Chinese online grocery firm Dada Nexus Ltd said on Monday it aims to raise up to US$280.5 million in a U.S. initial public offering (IPO), attempting a listing on New York's Nasdaq at a time of deepening tensions between Washington and Beijing. The company set a price range...
Slower economic growth expectations prompted Citi on Monday to slash its forecasts for global remittances, saying this raised the risk to credit ratings of smaller emerging market countries and was set to push up their borrowing costs.
Nissan Motor Co has estimated the closure of its plants in Barcelona could cost up to around 1.5 billion euros (US$1.7 billion), a union source told Reuters on Monday.
Shares of Pfizer Inc fell nearly 8per cent on Monday after an independent data monitoring committee determined the drugmaker's breast cancer treatment was unlikely to meet the main goal of a late-stage study.
